www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Release

 << Back



Taro to Report 2nd Quarter 2003 Results and Conduct Conference Call on July 24, 2003

PDF Version

HAWTHORNE, N.Y.--(BUSINESS WIRE)--July 10, 2003--Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS: TARO) intends to report financial results for the second quarter of 2003 prior to the Nasdaq market opening on Thursday, July 24, 2003. The Company will conduct a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).

The conference call will be hosted by Barrie Levitt, M.D., Chairman of the Company, who will review the quarter along with Kevin Connelly, Chief Financial Officer, and Daniel Saks, Vice President, Corporate Affairs. The call will be available live via the Internet by accessing www.taro.com.

Online and telephone replays of the call will be available from approximately 1:00 p.m. on July 24th through July 31, 2003. The online replay can be accessed at www.taro.com. The telephone replay can be heard by dialing 1-800-428-6051 (domestic U.S.) or +973-709-2089 (international) and providing the passcode 300842 when prompted.

Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

For more information on Taro, please visit www.taro.com.


    CONTACT: Taro Pharmaceutical Industries Ltd. Daniel Saks, 914-345-9000 ext. 208
             or:
             Kevin Connelly, 914-345-9000 ext. 338

    SOURCE: Taro Pharmaceutical Industries Ltd.
Terms of Use		 |
Privacy Statement		 |
Safe Harbor Statement